WASHINGTON (dpa-AFX) - St. Jude Medical, Inc. (STJ) announced FDA approval of its Ellipse implantable cardioverter defibrillator, or ICD.
ICDs are advanced implantable devices that treat potentially lethal, abnormally fast heart rhythms that often lead to sudden cardiac death.
The Ellipse ICD's unique shape was conceptualized by physicians during focus groups where they crafted in clay their vision for the ideal device design. The physician-inspired shape is unlike any device currently available and designed to increase patient comfort and physician ease-of-use. The angled header and rounded edges were designed to improve the way a lead wraps around the device once connected, which can result in a smaller incision and reduced pocket size for the device.
Copyright RTT News/dpa-AFX
© 2012 AFX News
